StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.55−0.30 (-2.76%)

Close on Nov 20, 2026Market cap $2.30BP/E –Yield –

Neogen net income

Net income is the profit left for shareholders after every expense, interest and tax.

Neogen's net income for the twelve months ending Aug 31, 2026 was -$56.12M. For fiscal 2026 it was -$7.90M. The highest annual figure on record is $63.15M in fiscal 2018.

Annual net income

PeriodPeriod endValueChange
FY2026May 31, 2026-$7.90M–
FY2025May 31, 2025-$1.09B–
FY2024May 31, 2024-$9.40M–
FY2023May 31, 2023-$22.87M-147.3%
FY2022May 31, 2022$48.31M-20.7%
FY2021May 31, 2021$60.88M+2.4%
FY2020May 31, 2020$59.48M-1.2%
FY2019May 31, 2019$60.18M-4.7%
FY2018May 31, 2018$63.15M+44.2%
FY2017May 31, 2017$43.79M+19.8%
FY2016May 31, 2016$36.56M+9.1%
FY2015May 31, 2015$33.53M+19.1%
FY2014May 31, 2014$28.16M+3.6%
FY2013May 31, 2013$27.19M+20.8%
FY2012May 31, 2012$22.51M-1.4%
FY2011May 31, 2011$22.84M+30.4%
FY2010May 31, 2010$17.52M–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026-$11.90M-132.8%
Q4 FY2026CQ2 2026May 31, 2026-$11.30M–
Q3 FY2026CQ1 2026Feb 28, 2026-$17.00M–
Q2 FY2026CQ4 2025Nov 30, 2025-$15.92M–
Q1 FY2026CQ3 2025Aug 31, 2025$36.30M–
Q4 FY2025CQ2 2025May 31, 2025-$612.20M–
Q3 FY2025CQ1 2025Feb 28, 2025-$10.90M–
Q2 FY2025CQ4 2024Nov 30, 2024-$456.28M–
Q1 FY2025CQ3 2024Aug 31, 2024-$12.61M-938.9%
Q4 FY2024CQ2 2024May 31, 2024-$5.39M-196.8%
Q3 FY2024CQ1 2024Feb 29, 2024-$2.02M-124.7%
Q2 FY2024CQ4 2023Nov 30, 2023-$3.49M–
Q1 FY2024CQ3 2023Aug 31, 2023$1.50M-71.1%
Q4 FY2023CQ2 2023May 31, 2023$5.57M-62.8%
Q3 FY2023CQ1 2023Feb 28, 2023$8.19M+50.5%
Q2 FY2023CQ4 2022Nov 30, 2022-$41.84M-486.4%
Q1 FY2023CQ3 2022Aug 31, 2022$5.21M-69.5%
Q4 FY2022CQ2 2022May 31, 2022$14.96M-5.1%
Q3 FY2022CQ1 2022Feb 28, 2022$5.44M-59.3%
Q2 FY2022CQ4 2021Nov 30, 2021$10.83M-31.8%
Q1 FY2022CQ3 2021Aug 31, 2021$17.08M+7.7%
Q4 FY2021CQ2 2021May 31, 2021$15.76M-3.6%
Q3 FY2021CQ1 2021Feb 28, 2021$13.38M+9.6%
Q2 FY2021CQ4 2020Nov 30, 2020$15.89M-2.4%
Q1 FY2021CQ3 2020Aug 31, 2020$15.86M+8.2%
Q4 FY2020CQ2 2020May 31, 2020$16.35M+3.4%
Q3 FY2020CQ1 2020Feb 29, 2020$12.20M-6.7%
Q2 FY2020CQ4 2019Nov 30, 2019$16.28M+1.4%
Q1 FY2020CQ3 2019Aug 31, 2019$14.65M-3.8%
Q4 FY2019CQ2 2019May 31, 2019$15.82M-9.9%
Q3 FY2019CQ1 2019Feb 28, 2019$13.07M-21.2%
Q2 FY2019CQ4 2018Nov 30, 2018$16.05M-6.1%
Q1 FY2019CQ3 2018Aug 31, 2018$15.24M+27.9%
Q4 FY2018CQ2 2018May 31, 2018$17.55M+40.7%
Q3 FY2018CQ1 2018Feb 28, 2018$16.59M+61.2%
Q2 FY2018CQ4 2017Nov 30, 2017$17.10M+53.3%
Q1 FY2018CQ3 2017Aug 31, 2017$11.91M–
Q4 FY2017CQ2 2017May 31, 2017$12.47M–
Q3 FY2017CQ1 2017Feb 28, 2017$10.29M–
Q2 FY2017CQ4 2016Nov 30, 2016$11.15M–

More Neogen figures

See a number that looks wrong?